Product
OSSM-001
2 clinical trials
2 indications
Indication
Acute GVHDIndication
Anorectal FistulaClinical trial
A Phase I Safety Study of Single Dose Allogeneic Bone Marrow Derived MSCs for Steroid Refractory Acute Graft vs. Host DiseaseStatus: Withdrawn, Estimated PCD: 2024-06-10
Clinical trial
A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's DiseaseStatus: Withdrawn, Estimated PCD: 2024-04-01